MARKET IS OPEN
Loading latest tickers...
Market Indices
S&P 500
$7,818.93
+0.58%
NASDAQ 100
$31,224.47
+0.48%
DOW JONES
$51,521.00
+0.49%
NASDAQ Composite
$27,599.79
+0.45%
RUSSELL 2000
$2,813.40
-0.72%
CBOE VIX
$15.01
-3.29%
Sector Heatmap
Technology+0.53%
Financials+0.24%
Healthcare-0.17%
Consumer Cycl+1.20%
Consumer Staples+0.90%
Energy+0.47%
Industrials+0.87%
Materials+0.46%
Real Estate+1.06%
Utilities+2.98%
Comm Services+0.04%
NRXS — Neuraxis, Inc.
NYSE AmericanNeuraxis, Inc.
$6.78
-0.37(-5.17%)
- O
- 7.20
- H
- 7.31
- L
- 6.76
- V
- 66.52K
⏱️ End-of-day dataAs of Oct 6, 2026
Chart
About NRXS
Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
IndustryELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
SectorNot available
IPO DateAug 9, 2023
Employees24
Stock ExchangeNYSE American
Ticker SymbolNRXS
Websitehttps://www.neuraxis.com
Key Financial Statistics
| Market Cap | $89.29M |
| P/E Ratio | N/A |
| Dividend Yield | None |
| EPS | N/A |
| Beta | N/A |
| 52-Week Range | $2.21 - $9.33 |
| 52-Week Avg Volume | 266.9K |
| VWAP | $6.98 |
| Transactions | 934 |
| Total Recorded Bars | 793 days |